⌕
Chemed · CHE · NYSE
Tenet 48 · Mixed
Compare
$546.75−0.49%At closeTenet 48 · Mixed
$546.75−2.70 (−0.49%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Chemed (CHE) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~4.3%/yr (FY21→FY25), net margin 10.5%, and free cash flow (~$325.5M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (142%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲4.1%
2,530.0
FY21→FY25CAGR +4.3%/yr
Net income ($M)▼12.2%
265.2
FY21→FY25CAGR −0.3%/yr
Free cash flow ($M)▼11.5%
325.5
FY21→FY25CAGR +6.8%/yr
Diluted EPS▼7.8%
18.34
buyback-liftedCAGR +2.1%/yr
What the receipts whisper · what a headline number hides
Share count
−9.3%

15.9mn → 14.5mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$62.8M

+26.8% YoY in FY25 · 2.5% of revenue.

Returns vs FCF
142%

$463.2M returned vs $325.5M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)2530.0Revenue−1706.8COGS823.2Gross profit−417.2SG&A338.2Op income−73.0Tax & other265.2Net income

10¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
403020100%sector median net margin ~3%FY21FY25

Over this window: gross 36.0% → 32.5%. Net margin 10.5% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,661.02,530.02,431.32,264.42,135.02,139.3▲4.1%+4.3%
Cost of revenue
1,768.51,706.81,576.91,465.61,369.91,369.5▲8.2%+5.7%
Gross profit
892.5823.2854.3798.8765.1769.8▼3.6%+1.7%
Selling, general & admin
446.5417.2424.4395.1358.7366.7▼1.7%+3.3%
Total operating expenses
521.7484.9487.9458.2421.6426.8▼0.6%+3.2%
Operating incomefeeds ROC rank
370.9338.2366.5340.6343.5343.0▼7.7%−0.4%
Other income, net
11.517.533.09.8−13.87.3——
Pretax income
382.3355.8399.5350.4329.7350.3▼10.9%+0.4%
Income tax
99.990.597.577.980.181.8▼7.1%+2.6%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
282.4265.2302.0272.5249.6268.6▼12.2%−0.3%
Per share
Diluted EPSbuyback-sensitive
20.8718.3419.8917.9316.5316.85▼7.8%+2.1%
Diluted shares (mn)
13.1314.4615.1915.2015.1015.94▼4.8%−2.4%
Margins
Gross margin17th pct in Healthcare
33.5%32.5%35.1%35.3%35.8%36.0%▼2.6pp−3.4pp
Operating margin
13.9%13.4%15.1%15.0%16.1%16.0%▼1.7pp−2.7pp
Net margin70th pct in Healthcare
10.6%10.5%12.4%12.0%11.7%12.6%▼1.9pp−2.1pp
† TTM = trailing four quarters through 2026-09-30.
FY08 – FY20 · 13 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-27 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Chemed's revenue last fiscal year?

Chemed reported revenue of $2,530.0M in fiscal 2025, up 4.1% from fiscal 2024.

What was Chemed's net income?

Chemed reported net income of $265.2M in fiscal 2025, a net margin of 10.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.